Clindamycin formulary restriction lowers costs, antimicrobial resistance.
D000900:Anti-Bacterial Agents / Q000191:economics / Q000627:therapeutic use*; D002981:Clindamycin / Q000191:economics / Q000627:therapeutic use*; D016360:Clostridioides difficile / Q000187:drug effects*; D003015:Clostridium Infections / Q000188:drug therapy* / Q000453:epidemiology; D003428:Cross Infection / Q000188:drug therapy* / Q000453:epidemiology; D003967:Diarrhea / Q000188:drug therapy* / Q000453:epidemiology; D004352:Drug Resistance, Microbial; D006801:Humans; D015994:Incidence; D010607:Pharmacy Service, Hospital / Q000191:economics*; D012307:Risk Factors
D000900:Anti-Bacterial Agents; D002981:Clindamycin